Deep Analysis of Impact of COVID-19 on “Cardiac Prosthetic Devices Market 2019-2025” Growth Worldwide….
The global cardiac
prosthetic device market
size is expected to be over USD 8.7
billion by 2025, based on a new study by Grand View Research, Inc. Rising
demand for minimally invasive devices has provided greater growth prospects for
the market. New product development through technological advancements is
anticipated to foster market growth. The major companies are focusing on
expanding their product life and safety benefits of the cardiac prosthetic
devices. Such initiatives undertaken by the key players have resulted in
increasing survival rates and low stroke rates for transcatheter aortic valves.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
Transcatheter aortic valve replacement
(TAVR) is covered by Evidence Development (CED) Coverage provided by the
Centers for Medicare & Medicaid Services (CMS). Cardiac pacemakers are also
covered under Medicare program. Initiatives for reimbursement from the
government for such devices are anticipated to boost the demand for cardiac
prosthetic devices.
Some key players include Medtronic, Inc.;
Boston Scientific Corporation; St. Jude Medical, Inc.; Edwards Lifesciences
Corporation; Siemens Healthcare GmbH; Abbott Vascular; and Sorin Group.
The companies are focusing on new
product development, geographical expansion, and mergers & acquisitions.
For instance, in 2016, St. Jude Medical announced the launch of Trifecta Valve
with Glide Technology in the U.S. They are utilizing advanced technology, which
is further expected to foster the growth of the industry.
To Request Sample Copy of this report, click the link:
Further Key Findings From the Study Suggest:
·
Heart valve segment was one of
the largest segments in 2015 owing to rising prevalence of valvular disease and
heart valve failure.
·
Pacemakers segment is expected
to grow significantly, owing to rising reimbursement policies for
pacemaker-related surgeries.
·
Mechanical heart valve segment
contributed toward the one of the largest market share in 2015 owing to its increasing
product longevity. Moreover, they provide better hemodynamic efficiency. Since
mechanical valves are made up of strong durable materials, such as titanium and
carbon, they are preferred over other cardiac prosthetic devices.
·
Transcatheter valve is expected
to exhibit lucrative CAGR over the forecast period. TAVR has shown improved
patient survival rate as compared to medical therapy. In the past years, it has
evolved as a minimally invasive alternative treatment for surgical valve
replacement.
·
Implantable pacemakers are one
of the highest revenue generating segments owing to their greater applicability
pertaining to heart failure (HF) and other cardiovascular diseases like stroke.
·
North America contributed
toward the largest market share of around 40.0% in 2015. This is primarily due
to the fact that the number of pacemaker implantations has increased amongst
the Americans over the past two decades. Moreover, companies are focusing on
commercial availability of technologically advanced devices in the U.S.
·
Asia Pacific is anticipated to
witness highest CAGR over the forecast period owing to the growing geriatric
population in Japan. In 2015, the geriatric population base accounted for
around 27% in Japan.
·
Some key companies
in cardiac prosthetic devices market are Medtronic, Inc.; St. Jude
Medical, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation;
Abbott Vascular; Siemens Healthcare GmbH; and Sorin Group.
·
New product development through
introduction of advanced technology and mergers & acquisitions are some of
the key strategies adopted by the companies to enhance the demand for cardiac
prosthetic devices. For instance, in 2015, St. Jude Medical and Thoratec, a
company that specializes in mechanical circulatory support technology for the
treatment of advanced HF, entered into a definitive agreement aiming at
acquisition of the outstanding shares of Thoratec.
The global cardiac prosthetic devices market size was valued at
USD 3.7 billion in 2015 and is expected to witness attractive growth over the
forecast period. The major companies are enhancing the longevity of their
product through technological advancements. These companies are also focusing
on expanding the safety of the cardiac prosthetic devices, which is expected to
increase the demand for such products.
Around 610,000 people are reported to die every year in the U.S.
owing to cardiovascular diseases. Disorders like stroke and prosthetic valve
failure lead to high mortality rates, which will impact the market to a great
extent, thereby, boosting the demand for valve replacement devices and
pacemakers. Stroke is one of the most frequently occurring cardiovascular
disorders amongst the geriatric population, which leads to acute prosthetic
heart failure. Dyspnea also leads to such heart failure, which is expected to
increase the need for products related to cardiac prosthetics.
Geriatric population plays a pivotal role in
the increasing demand for cardiac prosthetic devices. They have a higher
susceptibility to develop degenerative cardiac diseases, which is expected to
positively impact the market to a great extent. Hence, with rising geriatric
population base, the risk of cardiovascular diseases is estimated to rise. Asia
Pacific experienced the maximum deaths in 2013 from such diseases. The
geriatric population base is also more likely to experience longer
hospitalization related to cardiovascular disorders.
Have any Query? Ask our Experts:
Grand View Research has segmented the global cardiac
prosthetic device market on the basis of product:
Cardiac Prosthetic Device Product Outlook
(Market Revenue in USD Million, 2014 - 2025)
·
Heart valves
o
Mechanical valve
o
Tissue valve
o Stented
tissue valve
o Stentless
tissue valve
o
Transcatheter valve
·
Pacemakers
o
Implantable pacemakers
o Single-Chamber
Battery Pacemaker
o Dual-Chamber
Battery Pacemaker
o Triple-Chamber
Battery Pacemaker
o
External pacemakers
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Comments
Post a Comment